1. Home
  2. MCHX vs ACOG Comparison

MCHX vs ACOG Comparison

Compare MCHX & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • ACOG
  • Stock Information
  • Founded
  • MCHX 2003
  • ACOG 2000
  • Country
  • MCHX United States
  • ACOG Canada
  • Employees
  • MCHX N/A
  • ACOG N/A
  • Industry
  • MCHX Business Services
  • ACOG
  • Sector
  • MCHX Consumer Discretionary
  • ACOG
  • Exchange
  • MCHX Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • MCHX 84.3M
  • ACOG 80.3M
  • IPO Year
  • MCHX 2004
  • ACOG N/A
  • Fundamental
  • Price
  • MCHX $2.05
  • ACOG $10.80
  • Analyst Decision
  • MCHX
  • ACOG Strong Buy
  • Analyst Count
  • MCHX 0
  • ACOG 1
  • Target Price
  • MCHX N/A
  • ACOG $20.00
  • AVG Volume (30 Days)
  • MCHX 40.1K
  • ACOG 67.2K
  • Earning Date
  • MCHX 08-07-2025
  • ACOG 08-14-2025
  • Dividend Yield
  • MCHX N/A
  • ACOG N/A
  • EPS Growth
  • MCHX N/A
  • ACOG N/A
  • EPS
  • MCHX N/A
  • ACOG N/A
  • Revenue
  • MCHX $47,951,000.00
  • ACOG $2,928,654.00
  • Revenue This Year
  • MCHX $5.77
  • ACOG N/A
  • Revenue Next Year
  • MCHX N/A
  • ACOG N/A
  • P/E Ratio
  • MCHX N/A
  • ACOG N/A
  • Revenue Growth
  • MCHX N/A
  • ACOG N/A
  • 52 Week Low
  • MCHX $1.26
  • ACOG $3.75
  • 52 Week High
  • MCHX $2.40
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 54.23
  • ACOG N/A
  • Support Level
  • MCHX $2.02
  • ACOG N/A
  • Resistance Level
  • MCHX $2.20
  • ACOG N/A
  • Average True Range (ATR)
  • MCHX 0.13
  • ACOG 0.00
  • MACD
  • MCHX -0.03
  • ACOG 0.00
  • Stochastic Oscillator
  • MCHX 33.33
  • ACOG 0.00

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: